Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: prediction of clinical status--is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

Cardiovasc Res. 2003 Feb;57(2):298-301. doi: 10.1016/s0008-6363(02)00781-2.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiomyopathy, Hypertrophic, Familial / diagnosis*
  • Cardiomyopathy, Hypertrophic, Familial / genetics
  • Female
  • Fetal Diseases / diagnosis
  • Genetic Testing / methods*
  • Humans
  • Mutation*
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Prognosis
  • Ventricular Myosins / genetics*

Substances

  • Ventricular Myosins